Literature DB >> 20566738

Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells.

Angela Giorgini1, Heather J Brown, Steven H Sacks, Michael G Robson.   

Abstract

A role for toll-like receptor 4 (TLR4) has been suggested in previous studies of glomerulonephritis, but the complex integration of these effects has not been explored. To separate effects on the innate and adaptive immune responses, we use the autologous nephrotoxic nephritis model with two disease induction protocols. First, we give a TLR4 ligand at the time of immunization and show the effects are mediated via TLR4 by comparing wild-type and TLR4-deficient mice. In wild-type mice histological measures of disease and serum creatinine are all at least twice as high as TLR4-deficient mice, due to an enhanced immune response to the nephritogenic sheep IgG. Second, we stimulate TLR4 later in the course of disease development and construct four groups of bone marrow chimeric or sham chimeric mice to study the role of TLR4 on bone marrow or renal cells. The most striking finding is that renal cell TLR4 stimulation increases glomerular crescent formation, with a mean of 21% and 25% in the two groups of mice with renal cell TLR4 compared with 0.1% and 0.6% in the two groups without, with differences mirrored by changes in serum creatinine. These findings, in a single disease model, illustrate that TLR4 stimulation triggers crescentic glomerulonephritis by effects on both the adaptive and innate immune response, with a crucial direct effect on renal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566738      PMCID: PMC2912109          DOI: 10.2353/ajpath.2010.091279

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs.

Authors:  Graciela Andonegui; Claudine S Bonder; Francis Green; Sarah C Mullaly; Lori Zbytnuik; Eko Raharjo; Paul Kubes
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  Toll-like receptors in innate immunity.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2005-01       Impact factor: 4.823

4.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 5.  Toll-like receptors and renal disease.

Authors:  Michael G Robson
Journal:  Nephron Exp Nephrol       Date:  2009-07-09

6.  Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Authors:  Jochen Reiser; Gero von Gersdorff; Martin Loos; Jun Oh; Katsuhiko Asanuma; Laura Giardino; Maria Pia Rastaldi; Novella Calvaresi; Haruko Watanabe; Karin Schwarz; Christian Faul; Matthias Kretzler; Anne Davidson; Hikaru Sugimoto; Raghu Kalluri; Arlene H Sharpe; Jordan A Kreidberg; Peter Mundel
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  Role of Toll-like receptor 4 in endotoxin-induced acute renal failure.

Authors:  Patrick N Cunningham; Ying Wang; Rongqing Guo; Gang He; Richard J Quigg
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

10.  EXPERIMENTAL GLOMERULONEPHRITIS. VI. THE AUTOLOGOUS PHASE OF NEPHROTOXIC SERUM NEPHRITIS.

Authors:  E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more
  12 in total

1.  Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury.

Authors:  Frank Heller; Sandra Frischmann; Maria Grünbaum; Walter Zidek; Timm H Westhoff
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

Review 2.  Investigating mechanisms of chronic kidney disease in mouse models.

Authors:  Allison A Eddy; Jesús M López-Guisa; Daryl M Okamura; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2011-06-22       Impact factor: 3.714

3.  Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.

Authors:  Bruns A Watts; Esther Tamayo; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

4.  Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.

Authors:  Jens H Westhoff; Alexander Fichtner; Sina Waldherr; Nikolaos Pagonas; Felix S Seibert; Nina Babel; Burkhard Tönshoff; Frederic Bauer; Timm H Westhoff
Journal:  Pediatr Nephrol       Date:  2016-06-11       Impact factor: 3.714

5.  S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions.

Authors:  Ruth J Pepper; Hsu-Han Wang; Gayathri K Rajakaruna; Eugenia Papakrivopoulou; Thomas Vogl; Charles D Pusey; H Terence Cook; Alan D Salama
Journal:  Am J Pathol       Date:  2015-03-07       Impact factor: 4.307

6.  Single-cell RNA Sequencing Identified Novel Nr4a1+ Ear2+ Anti-Inflammatory Macrophage Phenotype under Myeloid-TLR4 Dependent Regulation in Anti-Glomerular Basement Membrane (GBM) Crescentic Glomerulonephritis (cGN).

Authors:  Jiaoyi Chen; Xiao Ru Huang; Fuye Yang; Wai Han Yiu; Xueqing Yu; Sydney C W Tang; Hui Yao Lan
Journal:  Adv Sci (Weinh)       Date:  2022-04-28       Impact factor: 17.521

7.  Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy.

Authors:  Thomas D Barbour; Guang Sheng Ling; Marieta M Ruseva; Liliane Fossati-Jimack; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  Kidney Int       Date:  2016-02-03       Impact factor: 10.612

8.  The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia.

Authors:  Tomoko Kanki; Takashige Kuwabara; Jun Morinaga; Hirotaka Fukami; Shuro Umemoto; Daisuke Fujimoto; Teruhiko Mizumoto; Manabu Hayata; Yutaka Kakizoe; Yuichiro Izumi; Saeko Tajiri; Tetsuya Tajiri; Kenichiro Kitamura; Masashi Mukoyama
Journal:  BMC Nephrol       Date:  2020-05-04       Impact factor: 2.388

Review 9.  Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective.

Authors:  Hernán Trimarchi
Journal:  Pediatr Nephrol       Date:  2021-07-27       Impact factor: 3.651

10.  Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.

Authors:  Simon J Freeley; Angela Giorgini; Calogero Tulone; Reena J Popat; Catherine Horsfield; Michael G Robson
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.